Rapid and sensitive liquid chromatography-tandem mass spectrometry for the quantitation of epirubicin and identification of metabolites in biological samples

Talanta

Volumn 72, Issue 1, 2007, Pages 145-154

  Wall, Rachel ^a   McMahon, Gillian ^a   Crown, John ^b   Clynes, Martin ^a   O'Connor, Robert ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Anthracyclines; Atmospheric pressure chemical ionisation (APCI); Cell culture; Epirubicin; Liquid chromatography mass spectrometry (LC MS); Serum

Indexed keywords

ATMOSPHERIC PRESSURE; CELL CULTURE; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

ANTHRACYCLINES; ATMOSPHERIC PRESSURE CHEMICAL IONISATION (APCI); ATMOSPHERIC PRESSURE CHEMICAL IONIZATION (APCI); EPIRUBICIN; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (LCMS); SERUM;

DRUG PRODUCTS;

EID: 33947309742     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2006.10.010     Document Type: Article

References (20)

1. Loadman P.M., and Calabrese C.R. J. Chromatogr. B 764 (2001) 193
2. Nielsen D., Maare C., and Skovsgaard T. Gen. Pharmacol. 27 (1996) 251
3. Hon Y.Y., and Evans W.E. Clin. Chem. 44 (1998) 388
4. Barker I.K., Crawford S.M., and Fell A.F. J. Chromatogr. B-Biomed. Applic. 681 (1996) 323
5. Andersson B.S., Eksborg S., Vidal R.F., Sundberg M., and Carlberg M. Toxicology 135 (1999) 11
6. Dollery C. Therapeutic Drugs (1991), Churchill Livingstone
7. Beijnen J.H., and Underberg W.J.M. J. Pharmaceut. Biomed. Anal. 6 (1988) 677
8. Arnold R.D., Slack J.E., and Straubinger R.M. J. Chromatogr. B-Anal. Technol. Biomed. Life Sci. 808 (2004) 141
9. Lachatre F., Marquet P., Ragot S., Gaulier J.M., Cardot P., and Dupuy J.L. J. Chromatogr. B 738 (2000) 281
10. Ricciarello R., Pichini S., Pacifici R., Altieri I., Pellegrini M., Fattorossi A., and Zuccaro P. J. Chromatogr. B 707 (1998) 219
11. Alvarez-Cedron L., Sayalero M.L., and Lanao J.M. J. Chromatogr. B 721 (1999) 271
12. Fogli S., Danesi R., Innocenti F., Di Paolo A., Bocci G., Barbara C., and Del Tacca M. Ther. Drug Monit. 21 (1999) 367
13. Sottani C., Tranfo G., Bettinelli M., Faranda P., Spagnoli M., and Minoia C. Rapid Commun. Mass Spectrom. 18 (2004) 2426
14. Duffy C.P., Elliott C.J., O'Connor R.A., Heenan M.M., Coyle S., Cleary I.M., Kavanagh K., Verhaegen S., O'Loughlin C.M., NicAmhlaoibh R., and Clynes M. Eur. J. Cancer 34 (1998) 1250
15. R. O'Connor, M. O'Leary, J. Ballot, C. D. Collins, P. Kinsella, D.E. Mager, R.D. Arnold, L. O'Driscoll, A. Larkin, S. Kennedy, D. Fennelly, M. Clynes, J. Crown, Cancer Chemother. Pharmacol. (2006) (in press).
16. Pfeifer T., Tuerk J., Bester K., and Spiteller M. Rapid Commun. Mass Spectrom. 16 (2002) 663
17. Shah V.P., Midha K.K., Dighe S., Mcgilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., Mcdowall R.D., Pittman K.A., and Spector S. J. Pharmaceut. Sci. 81 (1992) 309
18. Ermer J. J. Pharmaceut. Biomed. Anal. 24 (2001) 755
19. O'Connor R., O'Leary M., Ballot J., Collins C.D., Kinsella P., Mager D.E., Arnold R.D., O'Driscoll L., Larkin A., Kennedy S., Fennelly D., Clynes M., and Crown J. Cancer Chemother. Pharmacol. (2006)
20. Eurachem/Citac, Eurachem/Citac Guide 4 (2000).